-
A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide. The states of Idaho, Kansas and Missouri can now move ahead with their efforts in U.S. District Court in Amarillo, where a nominee of former President Donald Trump is the only judge.
-
The bill would reclassify mifepristone and misoprostol as Schedule IV substances. Doctors say doing so could cause delays in care during serious medical emergencies.
-
The court said that the challengers, a group called the Alliance for Hippocratic Medicine, had no right to be in court at all since neither the organization nor its members could show they had suffered any concrete injury.
-
A Texas federal judge revoked FDA approval of the self-managed abortion drug in April.
-
The Supreme Court has left the case in the hands of the 5th U.S. Circuit Court of Appeals, which has scheduled oral arguments in the case for May 17.
-
Supreme Court Justice Samuel Alito has placed a hold on a lower court ruling that restricts access to the abortion drug mifepristone until Wednesday night.
-
The Justice Department is seeking emergency relief from the U.S. Supreme Court in a Texas case involving limited access to the abortion drug mifepristone.
-
A Texas federal judge revoked long-standing FDA approval of a drug used to self-manage abortions and miscarriages. Abortion rights supporters say that will have wide-ranging repercussions for Texans, who already face extreme barriers to accessing reproductive care.